OVARIAN ENDOMETRIOID CARCINOMA

OVARIAN ENDOMETRIOID CARCINOMA was reported 42 times

OVARIAN ENDOMETRIOID CARCINOMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TESTOSTERONE UNDECANOATE 2 0.0010
1 FLURBIPROFEN 1 0.0007
2 TESTOSTERONE ENANTHATE 1 0.0006
3 MEGESTROL ACETATE 2 0.0005
4 TESTOSTERONE 9 0.0004
5 GOLIMUMAB 3 0.0002
6 LETROZOLE TABLETS 6 0.0001
7 LETROZOLE 6 0.0001
8 VITAMIN E 2 0.0001
9 PALBOCICLIB 6 0.0001
10 PACLITAXEL 6 0.0001
11 CARBOPLATIN 6 0.0000
12 NIRAPARIB 1 0.0000
13 INSULIN GLARGINE-YFGN 1 0.0000
14 FULVESTRANT 1 0.0000
15 BEVACIZUMAB 3 0.0000
16 BACLOFEN 2 0.0000
17 DOCUSATE SODIUM 1 0.0000
18 CITALOPRAM 2 0.0000
19 METHYLPREDNISOLONE 2 0.0000
20 EZETIMIBE 1 0.0000
21 LEUPROLIDE ACETATE 1 0.0000
22 FINGOLIMOD HCL 1 0.0000
23 AZATHIOPRINE 1 0.0000
24 NATALIZUMAB 2 0.0000
25 USTEKINUMAB 1 0.0000
26 ATENOLOL 1 0.0000
27 HYDROCHLOROTHIAZIDE 1 0.0000
28 AMLODIPINE BESYLATE 1 0.0000
29 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
30 CYCLOPHOSPHAMIDE 1 0.0000
31 RIVAROXABAN 1 0.0000
32 INFLIXIMAB 1 0.0000
33 INSULIN GLARGINE 1 0.0000
34 LISINOPRIL 1 0.0000
35 OMEPRAZOLE MAGNESIUM 1 0.0000
36 METHOTREXATE SODIUM 1 0.0000
37 ASPIRIN 1 0.0000
38 ADALIMUMAB 1 0.0000